The Scott Partnership Selected as Agency of Record by Sage-N Research
News May 13, 2010
B2B PR agency The Scott Partnership announces that it has been appointed by San Jose, California-based Sage-N Research, a proteomics data analysis solutions provider and developer of proprietary SEQUEST 3G and Sorcerer 2 solutions, to lead a global PR campaign aimed at increasing visibility of Sage-N Research in the scientific community as a leader in Computational Proteomics Platforms.
The Scott Partnership was appointed as agency of record due to its specialist experience in delivering successful PR campaigns for companies working within mass spectrometry, proteomics, informatics and life science.
With the ability to support campaigns in North America, China and Europe through its strategically placed offices, The Scott Partnership will use its expertise and hands-on approach in building company and brand awareness across multiple geographies to develop and manage a global PR campaign articulating Sage-N Research's global platform in protein discovery.
Sage-N Research is easy to use Integrated Data Appliances (IDA's) for mass spectrometry and proteomic research. Specializing in appliances designed to fully characterize proteins in complex biological samples, Sage-N Research is dedicated to developing a platform for the protein-based translational research, including biomarkers, molecular profiling, and target discovery. Through its next generation software for translational proteomics research, Sage-N Research is helping to accelerate the pace of drug discovery in cancer and stem cell research.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
Ataxin Links Long Term-Memory and NeurodegenerationNews
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in motor neuron disease (MND)READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE